Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68382-035

7 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68382-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 01)

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 01)
Chemical structure of venlafaxine hydrochloride showing the molecular arrangement of atoms including a methoxy-substituted phenyl ring, a cyclohexane ring, and an amine group with its hydrochloride salt form indicated.*
FDA Label Image

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 02)

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 02)
A pharmacokinetic fold change chart showing the effects of various special populations on venlafaxine and ODV analytes, measuring Cmax and AUC values. Populations include hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age above 60 years, and gender differences. The chart plots fold changes relative to a reference value with a 90% confidence interval.*
FDA Label Image

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 03)

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 03)
Chart depicting the pharmacokinetic fold change and 90% confidence intervals for venlafaxine when interacting with various drugs, including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The plot shows change relative to the reference value across parameters Cmax, AUC, and ODV for venlafaxine.*
FDA Label Image

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 04)

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 04)
A forest plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes relative to a reference value. The chart lists interacting drugs and their analytes on the left, with data points plotted on the right to illustrate changes, ranging approximately from 0 to 3 fold change. Drugs include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*
FDA Label Image

Sl-37.5mg-1000c (8c02c121 Fe14 45f5 B2bc B09fd377531f 05)

Sl-37.5mg-1000c (8c02c121 Fe14 45f5 B2bc B09fd377531f 05)
Label for venlafaxine hydrochloride extended-release capsules, USP, showing a strength of 37.5 mg. The label includes the NDC 68382-034-10, a quantity of 1,000 capsules, and indicates Rx only. It displays manufacturer and distributor information for Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc., with storage instructions and a warning to keep out of reach of children.*
FDA Label Image

Sl-75 mg -1000c (8c02c121 Fe14 45f5 B2bc B09fd377531f 06)

Sl-75 mg -1000c (8c02c121 Fe14 45f5 B2bc B09fd377531f 06)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg by Zydus Pharmaceuticals USA Inc. The label shows the product name, dose strength, package count of 1,000 capsules, and storage instructions at controlled room temperature. It includes directions to see the package insert for dosage and a reminder to keep out of reach of children.*
FDA Label Image

Sl-150mg-1000c (8c02c121 Fe14 45f5 B2bc B09fd377531f 07)

Sl-150mg-1000c (8c02c121 Fe14 45f5 B2bc B09fd377531f 07)
Label for venlafaxine hydrochloride extended-release capsules, USP 150 mg by Zydus Pharmaceuticals USA Inc. The label shows a prescription bottle containing 1,000 capsules, with storage instructions and dispensing information. The label includes a barcode, NDC 68382-036-10, and directions to provide a Medication Guide separately.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.